background
porcin
reproduct
respiratori
syndrom
viru
prrsv
one
import
infecti
agent
swine
industri
worldwid
zinc
zn
salt
wide
use
dietari
supplement
swine
nutrit
shown
antivir
effect
vitro
well
vivo
purpos
studi
determin
influenc
dietari
zinc
oxid
supplement
vaccin
challeng
infect
prrsv
find
clinic
cours
prr
success
vaccin
experiment
inactiv
vaccin
compar
anim
receiv
convent
diet
ppm
zn
control
group
diet
supplement
zn
oxid
zno
final
zn
concentr
ppm
pig
receiv
higher
dietari
zn
level
show
tendenc
toward
higher
neutral
antibodi
level
infect
dietari
zn
level
substanti
influenc
number
antivir
ifngamma
secret
cell
ifngammasc
percentag
blood
immun
cell
subset
infect
final
feed
higher
dietari
zn
level
reduc
neither
clinic
symptom
viral
load
conclus
result
suggest
higher
level
dietari
zno
potenti
stimul
modul
system
immun
respons
vaccin
heterolog
prrsv
infect
extent
could
improv
clinic
virolog
outcom
porcin
reproduct
respiratori
syndrom
prr
one
signific
swine
diseas
worldwid
effici
prr
viru
prrsv
vaccin
would
invalu
minim
clinic
econom
impact
prrsv
infect
current
safe
effect
vaccin
protect
wide
varieti
strain
avail
zinc
zn
ion
salt
exhibit
broadspectrum
antivir
activ
varieti
virus
vitro
includ
anim
virus
equin
arter
viru
transmiss
gastroenter
viru
european
union
standard
dietari
zn
level
feedingstuff
limit
ppm
due
environment
reason
howev
countri
high
level
infe
zn
oxid
zno
ppm
may
ad
diet
pig
restrict
period
follow
wean
prevent
postwean
diarrhea
high
level
zno
proven
conserv
intestin
flora
critic
period
follow
chang
diet
place
wean
despit
effect
exact
mechan
zno
action
remain
uncertain
local
system
effect
zno
specif
viral
pathogen
also
remain
larg
unknown
evalu
system
effect
differ
zn
level
ad
convent
diet
contain
ppm
zn
zn
low
control
group
prrsv
two
group
fed
diet
supplement
zno
final
concentr
ppm
zn
zn
med
ppm
zn
zn
high
half
anim
receiv
singl
vaccin
experiment
uvinactiv
type
prrsv
lelystad
viru
lv
sinc
shown
similar
vaccin
viru
combin
suitabl
adjuv
could
strongli
prime
virusneutr
vn
respons
reduc
durat
viremia
homolog
challeng
contrast
vanhe
et
al
chose
singlevaccin
approach
challengeinfect
anim
heterolog
type
prrsv
sequenc
ident
envelop
glycoprotein
bear
major
neutral
epitop
order
test
influenc
elev
zn
level
suboptim
antigen
stimulu
crossprotect
studi
approv
local
anim
welfar
author
landesamt
gesundheit
und
sozial
berlin
germani
registr
number
g
german
landrac
piglet
n
sex
prrsvfree
herd
wean
age
day
move
biosafeti
level
experiment
facil
bundesinstitut
risikobewertung
berlin
germani
randomli
alloc
six
pen
n
per
pen
piglet
assign
three
differ
diet
pen
per
diet
age
day
anim
receiv
zn
high
diet
switch
zn
med
diet
order
avoid
toxic
effect
zn
one
week
commenc
differ
diet
one
pen
per
diet
chosen
randomli
anim
vaccin
intramuscularli
inactiv
lv
access
kindli
provid
prof
h
nauwynck
ghent
univers
ghent
belgium
four
week
vaccin
age
day
pig
challeng
prrsv
field
strain
cresa
access
kindli
provid
prof
j
prof
e
mateu
cresa
barcelona
spain
anim
infect
intranas
applic
ml
viru
suspens
titer
tcid
ml
nostril
use
spray
nebul
pig
monitor
daili
presenc
clinic
sign
bodi
weight
record
weekli
blood
sampl
collect
weekli
vaccin
day
post
infect
dpi
nasal
swab
taken
dpi
blood
sampl
quantif
viru
shed
pig
necropsi
day
pi
lung
lymphoid
tissu
evalu
visual
inspect
macroscop
lesion
sampl
lung
lymph
node
tonsil
spleen
taken
immedi
frozen
liquid
nitrogen
store
virolog
analysi
serum
sampl
dpi
nasal
swab
dpi
tonsil
lung
tracheobronchi
lymph
node
sampl
dpi
examin
qpcr
determin
prrsv
copi
number
rna
extract
perform
use
viral
rnadna
purif
kit
stratec
appli
serum
mg
tissu
rna
yield
qualiti
determin
spectrophotomet
nanodrop
technolog
revers
transcript
rt
perform
use
cdna
synthesi
kit
thermo
fisher
scientif
viral
load
quantifi
use
taqman
fluoresc
probebas
realtim
qpcr
assay
icycl
detect
system
biorad
primer
describ
elsewher
prrsvspecif
igm
igg
antibodi
measur
elisa
ingezim
prr
dr
ingenasa
accord
manufactur
instruct
vn
antibodi
prrsv
quantifi
viral
neutral
test
previous
describ
neutral
prrsv
strain
cresa
examin
use
prrsv
specif
monoclon
antibodi
ingenasa
alexa
conjug
antimous
igg
h
l
secondari
antibodi
invitrogen
peripher
blood
mononuclear
cell
pbmc
isol
use
densiti
centrifug
ficol
gradient
paa
laboratori
sampl
treat
erythrocyt
lysi
buffer
min
ice
pbmc
wash
ml
pb
bsa
centrifug
min
g
sampl
pbmc
viabil
confirm
use
standard
procedur
cellmedi
prrsvspecif
immun
respons
measur
use
elispot
enumer
ifngammasc
pbmc
mabtech
order
compar
homolog
heterolog
respons
pbmc
stimul
parallel
pbmcwell
well
per
pig
stimulu
cresa
lv
multipl
infect
unstimul
phastimul
cell
use
neg
posit
control
respect
ifngammasc
number
count
use
elispot
reader
system
ael
vi
gmbh
flow
cytometri
analysi
perform
describ
use
bd
flow
cytomet
bd
bioscienc
data
analyz
softwar
treestar
almost
infect
pig
show
clinic
symptom
typic
prrsv
infect
similar
previou
studi
prrsv
strain
increas
rectal
temperatur
detect
day
edema
eyelid
conjunct
day
signific
dietari
effect
fever
magnitud
durat
figur
b
clinic
sign
cough
observ
sporad
last
day
regard
weight
gain
could
analyz
effect
zn
med
diet
vaccin
group
given
time
point
miss
pig
receiv
zn
high
pig
remain
time
point
well
nonvaccin
group
found
benefit
feed
higher
dietari
zn
level
figur
c
mean
prrsv
load
serum
determin
qpcr
peak
dpi
gradual
reduc
later
neither
vaccin
elev
zn
level
show
influenc
prrsv
viremia
time
observ
period
figur
b
observ
regard
viru
shed
determin
analysi
nasal
swab
figur
c
persist
viru
found
dpi
major
tonsil
sampl
regardless
diet
lung
tracheobronchi
lymph
node
sampl
test
neg
presenc
prrsv
genom
prrsvspecif
igg
igm
antibodi
detect
elisa
randomli
chosen
sampl
nonvaccin
infect
day
infect
day
one
vaccin
anim
posit
prrsv
antibodi
figur
b
contrast
previou
result
show
earlier
seroconvers
vaccin
uvinactiv
lv
might
due
fact
use
cell
cultureadapt
nonpurifi
lv
possibl
decreas
immunogen
compar
purifi
lv
grown
porcin
alveolar
macrophag
use
cite
studi
dpi
piglet
group
seroposit
except
pig
vaccin
nonvaccin
zn
low
group
higher
p
antibodi
level
detect
vaccin
group
nonvaccin
group
dpi
prrsv
challeng
diet
influenc
antibodi
level
gener
neutral
antibodi
delay
prrsv
infect
usual
appear
three
four
week
infect
accordingli
studi
viru
neutral
vn
antibodi
detect
dpi
serum
singlevaccin
inactiv
lv
lead
earlier
induct
vn
antibodi
vaccin
group
develop
higher
p
vn
antibodi
titer
nonvaccin
counterpart
dpi
figur
tendenc
toward
higher
vn
antibodi
level
evid
pig
receiv
higher
level
zn
zn
med
dpi
tendenc
continu
dpi
zn
med
zn
high
group
thu
possibl
remain
anim
receiv
higher
dietari
zn
level
might
better
protect
reinfect
prrsv
number
ifngammasc
dpi
reveal
differ
homolog
heterolog
restimul
addit
file
flow
cytometri
analysi
pbmc
phenotyp
perform
weekli
day
day
post
infect
singl
vaccin
delay
prevent
prrsvinduc
decreas
cell
popul
import
viral
clearanc
found
sustain
effect
dietari
zn
level
analys
cell
subset
addit
file
necropsi
dpi
reveal
gross
lung
lesion
lymphoid
hyperplasia
tonsil
lymph
node
spleen
pig
overal
studi
show
challeng
infect
wildtyp
prrsv
without
addit
environment
social
stress
impact
secondari
infect
result
rel
mild
clinic
sign
condit
elev
dietari
zn
level
could
provid
enhanc
protect
infect
type
prrsv
field
strain
could
improv
efficaci
singlevaccin
heterolog
inactiv
vaccin
data
set
support
result
articl
includ
within
articl
addit
file
addit
file
figur
prrsvspecif
number
ifngammasc
determin
elispot
pbmc
collect
dpi
restimul
either
prrsv
strain
lv
cresa
use
studi
result
shown
averag
frequenc
virusspecif
ifngammasc
per
pbmc
fill
symbol
indic
result
obtain
vitro
restimul
prrsv
use
infect
homolog
empti
symbol
show
result
vitro
restimul
lv
heterolog
addit
file
figur
modul
pbmc
immun
cell
frequenc
determin
flow
cytometri
analysi
b
cytotox
lymphocyt
high
c
h
cell
e
f
cell
g
h
antibodi
form
memori
b
cell
j
nk
cell
asterisk
indic
statist
signific
differ
p
averag
dpi
